4//SEC Filing
Spaventa Andrew 4
Accession 0000950170-24-137425
CIK 0001850906other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:36 PM ET
Size
13.5 KB
Accession
0000950170-24-137425
Insider Transaction Report
Form 4
Spaventa Andrew
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2024-12-16$20.16/sh−180$3,629→ 631 total - Exercise/Conversion
Common Stock
2024-12-15+486→ 811 total - Exercise/Conversion
Restricted Stock Units
2024-12-15−486→ 4,374 total→ Common Stock (486 underlying) - Gift
Common Stock
2024-12-16+306→ 141,793 total(indirect: By Trust) - Gift
Common Stock
2024-12-16−306→ 325 total
Holdings
- 85(indirect: By LLC)
Common Stock
Footnotes (7)
- [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted RSUs.
- [F3]Weighted average price. These shares were sold in multiple transactions at prices ranging from $20.07 to $20.34 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]Immediately upon settlement of the vested RSUs, and following the withholding described above, the Reporting Person transferred the shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
- [F5]The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- [F6]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F7]The RSUs vest in 16 equal quarterly installments over four years measured from March 15, 2023.
Documents
Issuer
Singular Genomics Systems, Inc.
CIK 0001850906
Entity typeother
Related Parties
1- filerCIK 0001859701
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:36 PM ET
- Size
- 13.5 KB